ORIC Pharmaceuticals Inc.

NASDAQ: ORIC · Real-Time Price · USD
9.72
-0.21 (-2.11%)
At close: Aug 15, 2025, 3:59 PM
9.62
-1.03%
After-hours: Aug 15, 2025, 06:39 PM EDT

ORIC Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
1.11M 1.03M 966K 897K
Gross Profit
-1.11M -1.03M -966K -897K
Operating Income
-142.9M -110.78M -91.77M -78.87M
Interest Income
n/a 10.08M 2.65M 141K
Pretax Income
-127.85M -100.7M -89.12M -78.72M
Net Income
-127.85M -100.7M -89.12M -78.72M
Selling & General & Admin
28.82M 25.61M 25.09M 22.01M
Research & Development
114.07M 85.17M 61.68M 56.86M
Other Expenses
-1.11M -1.03M -966K n/a
Operating Expenses
141.79M 109.75M 85.8M 78.87M
Interest Expense
n/a n/a 2.65M n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
142.9M 110.78M 86.77M 78.87M
Income Tax Expense
n/a n/a 2.35M -1.04M
Shares Outstanding (Basic)
69.73M 51.45M 39.66M 37.95M
Shares Outstanding (Diluted)
69.73M 51.45M 39.66M 37.95M
EPS (Basic)
-1.83 -1.96 -2.25 -2.07
EPS (Diluted)
-1.83 -1.96 -2.25 -2.07
EBITDA
-126.74M -109.75M -88.16M -77.97M
EBIT
-127.85M -110.78M -89.12M -78.72M
Depreciation & Amortization
1.11M 1.03M 966K 897K